NCT01949051 - A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2013

Primary Completion Date

February 4, 2014

Study Completion Date

February 4, 2014

Conditions

Rhinitis, Allergic, Perennial and Seasonal

Interventions

DRUG

Levocabastine

Intranasal aqueous 50 mcg microsuspension of levocabastine supplied in an amber glass bottle fitted with a white top actuated plastic metering atomising spray pump filled with a uniform white suspension

DRUG

Placebo

Intranasal aqueous 0 mcg microsuspension supplied in an amber glass bottle fitted with a white top actuated plastic metering atomising spray pump filled with a uniform white suspension

Trial Locations (1)

L4W 1A4

GSK Investigational Site, Mississauga